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Abstract Establishment of continuous cell lines
from human normal and tumor tissues is an extended
and useful methodology for molecular characteriza-
tion of cancer pathophysiology and drug development
in research laboratories. The exchange of these cell
lines between different labs is a common practice that
can compromise assays reliability due to contamina-
tion with microorganism such as mycoplasma or cells
from different flasks that compromise experiment
reproducibility and reliability. Great proportions of
cell lines are contaminated with mycoplasma and/or
are replaced by cells derived for a different origin
during processing or distribution process. The scien-
tific community has underestimated this problem and
thousand of research experiment has been done with
cell lines that are incorrectly identified and wrong
scientific conclusions have been published. Regular
contamination and authentication tests are necessary
in order to avoid negative consequences of widespread
misidentified and contaminated cell lines. Cell banks
generate, store and distribute cell lines for research,
being mandatory a consistent and continuous quality
program. Methods implementation for guaranteeing
both, the absence of mycoplasma and authentication in
the supplied cell lines, has been performed in the
Andalusian Health System Biobank. Specifically,
precise results were obtained using real time PCR
detection for mycoplasma and 10 STRs identification
by capillary electrophoresis for cell line authentica-
tion. Advantages and disadvantages of these protocols
are discussed.
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Introduction
The use of cultured cells that acquired the ability to
proliferate indefinitely is an extended tool in research
laboratories. Cell lines are used as in vitro models of
health and disease by retaining many of the properties
of the parental tissue or cell type, including disease-
specific changes (Christine Alston-Roberts et al. 2010;
Shannon et al. 2016). Because of those reasons, cell
lines based screening platforms are excellent models
to test new therapeutic approaches.
Nowadays is frequent the exchange of established
cells between different laboratories as result of groups
interactions. That practice involves a high risk of cell
lines contamination by two common sources: amicroor-
ganism, usually mycoplasma, or a foreign cell line.
Many cell lines currently used are contaminated with
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mycoplasma and/or are replaced by cells derived for a
different origin without researcher knowledge (Capes-
Davis et al. 2010; Drexler et al. 2017). The conse-
quences of widespread misidentified and contaminated
cell lines are immeasurable and it cannot be ignored by
the scientific community (Huang et al. 2017).
Mycoplasma contamination of cell cultures was
first described in the 1950s (Macpherson 1966).
Mycoplasmas and the related Acholeplasmas (both
referred as ‘‘mollicutes’’) are the smallest self repli-
cating bacteria and the most prevalent microbial
contaminant of cell. These microorganisms pass
through standard 0.22 lm filter, are not affected by
commonly used antibiotics in cell mediums and can
grow until extremely high titres without producing any
turbidity in the supernatants. Between 18 and 31% of
cell cultures are contaminated with mycoplasma
(Macpherson 1966) affecting seriously to the exper-
imental results of cell viability, gene expression, cell
morphology and metabolism and growing rate
(Nubling et al. 2015). Mycoplasma contamination
may affect both the scientific results of cell culture-
based research and the quality of biological medicines
manufactured by cell culture in the biopharmaceutical
industry for therapeutic use (Armstrong et al. 2010;
Laborde et al. 2010; Volokhov et al. 2011). The
common sources of mycoplasma contamination are:
cross-contamination of cell lines from other my-
coplasma-positive cell cultures, researchers, labora-
tory equipment, contaminated reagents, the N2 liquid
of cryostorage vessels, feeder cell cultures and labo-
ratory animals. Because of the magnitude of this
problem a periodic mycoplasma detection test must be
performed in every cell line manipulated in the
laboratory. In fact, scientific journals are requiring
free mycoplasma cell lines before accepting manu-
scripts for publication (Geraghty et al. 2014).
Cell line misidentification is the other one of the
most serious and persistent problems detected in
culture laboratories (Geraghty et al. 2014; Drexler
et al. 2017; Huang et al. 2017). Cross-contamination
between cell lines may be due to several reasons such
as an accidental contact, contaminated mediums or
reagents, the use of mitotically inactivated feeder
layers or conditioned medium which may carry
contaminating and not properly eliminated cells (van
Pelt et al. 2003). Besides, a cell line can be replaced by
another because of mislabeling or confusion during
handling (Christine Alston-Roberts et al. 2010).
Because of those reasons, established cell lines need
to be authenticated by a reference standard method
(Ayyoob et al. 2015).
Different methods for cell lines authentication have
been described: chromosomal analysis/karyotyping
(MacLeod et al. 2007), isoenzyme analysis (Stacey
et al. 1997), multilocus DNA fingerprint analysis
(Jeffreys et al. 1985; Stacey et al. 1992), short tandem
repeat (STR) profiling (Masters et al. 2001; Butler
2006), polymerase chain reaction fragment analysis
(Steube et al. 2008) and sequencing of ‘‘DNAbarcode’’
regions (Hebert et al. 2003). The selection of a specific
method depends on the researcher’s purpose, the
expected resolution and the laboratory’s expertise.
By other hand, the discovery of DNA hypervariable
regions within genomes has made possible to identify
each human cell line derived from a single donor.
Jeffreys et al. (1985) demonstrated in 1985 that
hypervariable regions, which consist of variable num-
ber tandem repeat (VNTR) units from minisatellite
DNA, are capable of hybridizing to many loci
distributed throughout the genome to produce a DNA
‘‘fingerprint’’. In spite of the intrinsic difficulties of
DNA fingerprint, subsequent advances in the technol-
ogy have given rise to the use of microsatellite regions
consisting of core sequences of 1–6 bp, repeated in a
different number in each cell line. Because the
polymorphism of STRs are hotspots for homologous
recombination events, these markers display many
variations in the number of the repeating units between
loci in unrelated cell lines (Wahls et al. 1990).
Cell banks generate, store and distribute controlled
cell lines. Their activity of stocks testing for my-
coplasma and authenticity minimizes the contamina-
tion risks associated with prolonged passaging
(Kiehlbauch et al. 1991). So, the implementing of a
consistent quality control in biobanking to guarantee
mycoplasma free and authentication of cell lines is
crucial (Cardoso et al. 2010). In order to establish a
cell lines quality control workflow different methods
were chosen and results were compared.
Materials and methods
Human biological samples
Handling of human biological samples was carried out
according to national legal framework [Law on
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Biomedicine Research (July 2007)]. The samples used
were collected following informed consent of the
donors and immediately anonymized. Local scientific
and ethic committees approved the procedures per-
formed in this work.
Cell lines supernatants
Twenty-four supernatant samples from tumor cell
lines generated by the Biobank were used to my-
coplasma detection. 100 ll supernatants were heated
at 95 C for 10 min and centrifuged at 1000 g for 5 s
to discard cellular debris.
Conventional PCR mycoplasma detection
LookOut mycoplasma PCR Detection Kit (Cat. no.
MP0035, Sigma-Aldrich, MO, USA) for detection of
19 mycoplasma species was used following the man-
ufacturer instructions formycoplasma detection in cell
cultures. PCRs were performed using an Eppendorf
AG thermocycler. Results were visualized using
Agilent DNA 1000 Reagents (Cat. no. 5067-1504,
Agilent Technologies, CA, USA) in a 2100 Bioana-
lyzer (Agilent Biotechnologies, CA, USA).
Real-time PCR mycoplasma detection
LookOut mycoplasma qPCR Detection Kit (Cat. no.
MP0040, Sigma-Aldrich, MO, USA) for detection of
66 mycoplasma species was used following manufac-
turer instructions for mycoplasma detection in cell
cultures. PCR inhibition was discarded by an internal
control from the kit (ROX labeled). PCRs were
performed with specific Taqman probes (FAM
labeled) using an ABI 7500 real time PCR thermocy-
cler (Applied Biosystems, Singapore, Asia).
DNA isolation for STRs analysis
DNA isolation from blood
For DNA isolation from blood samples, the paramag-
netic beads based instrument Chemagic MSMI (Perk-
inElmer Inc., MA, USA) was used. Briefly, Chemagic
DNABlood Kit special (PerkinElmer Inc., Cat.# CMG-
703-1,MA, USA) was used for 3 ml of blood following
manufacturer instructions. The corresponding Tris–HCl
elution buffer available in the kits was used.
DNA isolation from frozen tissues
For DNA isolation from tissues sections the param-
agnetic beads based instrument Chemagic MSMI
(PerkinElmer Inc., MA, USA) was used. Chemagic
DNA Blood Kit special (Cat. no CMG-703-1, Perk-
inElmer Inc., MA, USA) was used for tissue sections
but with Proteinase K for tissue (Cat. no 834,
PerkinElmer Inc., MA, USA) and Lysis Buffer 1 for
tissue (Cat. no 805, PerkinElmer Inc., MA, USA).
Between 10 and 18 20-lm sections for frozen tissues
OCT were used (the exact number of sections varied
with the area occupied by the tissue after hematoxylin
staining). Tris–HCl elution buffer available in the kits
was used.
DNA isolation from cell lines
Cell pellets were used for DNA isolation (106 cells).
QIAamp DNA Mini Kit (Cat. no 51304, Qiagen; MD,
USA) was used in a Qiacube robot following manu-
facturer instructions.
DNA isolation from blood spot stored in FTA cards
The 1.2 mm Harris Uni-core punch (Whatman, MO,
USA) was used to obtain a FTA 1.2 mm disc that was
introduced in a 0.2 ml PCR tube. DNA was purified
from blood sample contained in the disc using the
Whatman FTA purification reagent (Cat. no
A719978-1EA, Sigma Aldrich, MO, USA) following
manufacturer instructions. Briefly, three washes were
performed with Whatman FTA purification reagent
followed by three washes with TE buffer. After TE
buffer elimination, the FTA disc was dried during 1 h
at room temperature. Dry FTA disc was used directly
for multiplex PCR.
Multiplex PCR for 5 STRs loci detection
Multiplex PCR for 5 STRs loci detection (DXS7132,
GATA31E08, DYS390, GATA71D03 and DXS6789)
was performed with primer sequences described by
other author(Gastier et al. 1995; Sheffield et al. 1995).
50 ng of DNA isolated from cell lines, blood or tissue,
or a pre-treated 1.2 mm FTA disc, were amplified
using the Type-it Microsatellite PCR kit (Cat. No.
206241, Qiagen; MD, USA) according to the manu-
facturer instructions. The PCR program used was 1
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cycle 95 C 5 s, 32 cycles (95 C 30 s, 57 C 30 s y
60 C 30 s), 1 cycle 60 C 30 min, on an Eppendorf
AG thermocycler (Eppendorf, Hamburg, Germany).
PCR products were analyzed by electrophoresis on a
3% and 25 cm long agarose gel stained with GelRed
(Cat. no 41003, Biotium, CA, USA). The GeneR-
ulerTM 100 bp Plus DNA Ladder (Cat n8 SM0321,
Thermo Scientific, MO, USA) was also run out as size
reference and results were visualized on a Chemidoc
instrument (Bio-Rad, CA, USA).
Multiplex PCR for 10 STRs loci detection
Multiplex PCR for 10 STRs loci detection (TH01,
TPOX, vWA, Amelogenin, CSF1P0, D16S539,
D7S820, D13S317, D5S818, D21S11) was performed
using 10 ng of DNA isolated from cell lines, blood or
tissue, or a pre-treated 1.2 mm FTA disc, and the
GenePrint 10 System (Cat. no B9510, Promega, WI,
USA) according to the manufacturer instructions.
STRs fragment detection was performed by capillary
electrophoresis in a 3130 genetic analyzer (Applied
Biosystems, Singapore, Asia) using the POP-7 matrix.
Data analysis was carried out with the GemaMapper
ID-X (v1.0.1) software (Life Technologies, CA,
USA).
Results
Twenty-four cell culture supernatant were used to
check and compare both detection method used in the
BBSSPA for mycoplasma detection by conventional
and real time PCR. By conventional PCR a 481 bp
band was visualized for internal control detection in
negative and positive samples and a specific
260 ± 8 bp band for mycoplasma positive samples
(Fig. 1a). Specific mycoplasma amplification was also
observed by real time PCR with internal control
detection for all the samples tested (Fig. 1b). With
both methods used, five samples from the twenty
supernatant samples analyzed were positive for my-
coplasma. In any case, no invalid results were
observed. A mycoplasma positive sample visualiza-
tion by both methods is shown in Fig. 1.
STRs analysis by Multiplex PCR for DNA isolated
from 10 cell lines, 4 tissues or 3 blood samples, or 3
pre-treated FTA discs, was performed by different
methods (5 STRs and 10 STRs loci detection).
Corresponding results to the same donor (10 pairs of
samples) were compared by both methods: 4 cell lines
were compared with the original tissue, 3 cell lines
were compared with frozen blood from the original
donor, and 3 cell lines were compared with FTA
punch. Coincident results were obtained for 5 STRs
and 10 STRs loci detection methods except for pre-
treated FTA discs, whose results were not precise
through 5 STRs loci Multiplex PCR (samples H, I and
J, Fig. 2). Clear results were obtained in any case with
Multiplex 10 STRs loci detection kit. Results for
Multiplex 10 STRs loci detection method is detailed in
Table 1.
Discussion
Contamination by mycoplasma and cell lines cross-
contamination are recognized as the most serious and
persistent problems in mammalian cell lines culture
(Geraghty et al. 2014), being a great source of false
scientific results (Drexler et al. 2003; Nubling et al.
2015; Drexler et al. 2017). Early cross-contamination
of a newly established cell line is usual and can result
in the worldwide spread of a misidentified cell line
(Chatterjee 2007).
Studies carried out in USA by FDA report that 15%
over 20,000 cell cultures were contaminated with
mycoplasma (Barile 1979). In Europe, mycoplasma
contamination levels detected were over 25% of 1949
cell cultures from the Netherlands and 37% of 327
cultures from Czechoslovakia (McGarrity 1988). The
incidence of mycoplasma contamination was reported
to be 57.5% in Iran (Molla Kazemiha et al. 2014), 80%
in Japan (Koshimizu and Kotani 1981) and 88.7% in
Mexico (Rivera et al. 2009). Published data from the
German Cell Lines Bank DSMZ inform that 187 from
598 leukemia-lymphoma cell lines (31%) were con-
taminated with mycoplasma (Capes-Davis et al. 2010)
and recent studies show a ratio of 24/82 cell cultures
contamination (29.3%) (Falagan-Lotsch et al. 2015).
These disturbing data are due to absent or inadequate
testing in many laboratories (Capes-Davis et al. 2010).
Otherwise, cell line misidentification is one of the
most serious and persistent problem in culture labs
originates from cross-contamination with another cell
line (Geraghty et al. 2014; Huang 2017). Usually
cross-contamination may occur at the beginning of the
cell line generation, so never has exist the pure cell
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line, and it’s impossible to have it. This fact is high
frequent because cultures can remain in crisis for a
prolonged period of time before emerging as an
immortalized line; in this period a foreign cell line can
be introduced in the culture and proliferate (Capes-
Davis et al. 2010).
Misidentification problem dates from 1950s.
Between 16 and 35% of cell lines used in experiments
have been misidentified or cross-contaminated with
other cell lines (Reid et al. 2013). Specifically, 18% of
252 submitted cell lines at German Cell Lines Bank
DSMZ were misidentified (Capes-Davis, Theo-
dosopoulos et al. 2010) and 95 of 380 cell lines
(25% of cross-contamination) used in China (Ye et al.
2015). Curiously, 93.22% of the foreign cells detected
in China were HeLa cells. Recently, 46.0% (128/278)
of misidentification for a panel of 278 cell lines from
28 institutes in China has been described by compar-
ing the DNA profiles with the cell bank databases of
ATCC and DSMZ (Huang et al. 2017). From 2012 to
2014, a 13.8% of misidentification was detected over
111 cell line authentication test performed by Cell
Line Authentication Service at Brazilian Metrology
Institute in Brazil, (Cosme et al. 2017). Results
derived from misidentified lines have been published
in thousands of articles and have been used in drugs
screening leading to unusable or even harmful ther-
apeutic strategies (Ye et al. 2015).
In spite of previous results, different works show the
high frequency of cell lines distribution between
laboratories versus the limited tests performed for
mycoplasma and authentication. According to a 2004
survey, 63% of researchers (n = 485) have acquired at
least one cell line from another laboratory, while 45%
have never tested their cell lines for authenticity
(Buehring et al. 2004). A 2013 survey disclose that
25% (n = 250) of laboratories do not perform my-
coplasma test (Shannon et al. 2016). Data from this
same survey show that 76% (n = 111) of users
obtained cell lines from other laboratories where
mycoplasma and authentication tests are not frequently
performed, and only 46% (115/250) of researchers that
typically perform authentication testing in their labo-
ratory (Shannon et al. 2016). Only 39.89% (79/198)
Fig. 1 Representative negative and positive results for mycoplasma detection. a Conventional PCR ? Bioanalyzer, b Real-time PCR
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and 69.19% (137/198) of researchers perform my-
coplasma and authentication analysis in samples
managed recently respectively, and 74.8% (187/250)
and 46% (115/250) of researchers have decided to
perform mycoplasma and authentication analysis
respectively, in the future (Shannon et al. 2016).
The World Health Organization propose to harmo-
nize assays for mycoplasma DNA detection (WHO
2014). A large number of methods with different
properties of sensitivity and specificity for my-
coplasma testing are available: microbiological cul-
ture, direct DNA staining, biochemical detection and
Nucleic Acid Amplification Techniques (NAT assays)
(Geraghty et al. 2014). Although microbiological
culture has been the ‘‘gold standard’’ for detection of
viable mycoplasma, the overall testing strategy is time
consuming (a minimum of 28 days) (Duke et al.
1966). The most extended and sensitive but not the
cheapest methods for mycoplasma testing are NAT
assays with their different variations: quantitative,
semiquantitative or qualitative (Sheppard et al. 2009).
NAT assays allow to have results in 2–3 h by using
real-time PCR, the specificity is really high, and detect
most of the Mollicutes species.
Fig. 2 Results obtained
using 5 STRs loci detection
method. Four cell lines were
compared with the original
tissue (A and A0, B and B0, C
and C0, D and D0), 3 cell
lines were compared with
frozen blood from the
original donor (E and E0, F
and F0, G and G0), and 3 cell
lines were compared with
FTA punch (H and H0, I and
I0, J and J0)
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Two different NAT assays were selected for
mycoplasma testing. Valid and coincident results were
obtained with both conventional and real time PCR
based methods. But important advantages are listed for
real-time PCR comparing conventional PCR. Real-
time PCR method is able to detect 66 different
mycoplasma species whereas conventional PCR
method only detects 19 (Table 2). The lower manip-
ulation in real-time PCR assays, linked to the fact that
in the real-time PCR method, PCR amplified tubes are
never opened in the laboratory, reduces drastically the
risk of contamination. Real-time PCR results are semi-
quantitative being indicative of the grade of my-
coplasma contamination in the cell culture. Addition-
ally, real-time PCR method interpretation is easier
thanks to the numeric value obtained and results
interpretation from Agilent chip by technicians is not
necessary. Finally and not less important, analysis
prize per sample is lower for real-time PCR method.
The concept of biochemical polymorphisms was
introduced in 1966 to distinguish human cell lines on
the basis of their isozymes expression (Gartler 1967).
Previously in 1962 the first bank of authenticated cell
lines was established at the ATCC using karyotyping
and immunological approaches (Christine Alston-
Roberts et al. 2010). Currently, the Short Tandem
Repeats (STR) profiling is the reference method for
cell line identification (Mehta et al. 2017), and
standard STRs profiling protocols have been estab-
lished by ATCC SDO workgroup ASN-002 for cell
line authentication (Christine Alston-Roberts et al.
2010). The presence of STRs within the human
genome exists at variable lengths throughout the
population. A cell line is considered authentic when
the STR profile shows at least 80% matching with the
original tissue or its derivatives (Rubocki et al. 2000).
Different starting material (blood, tissue and FTA
punches) for DNA isolation was used to validate the
Table 1 Results obtained using multiple 10 Strs detection method
Samples Analized STRs
AMEL CSF1PO D13S317 D16S539 D21S11 D5S818 D7S820 TH01 TPOX VWA
A X 11, 12 10, 11 8, 9 28, 32.2 11, 13 10, 12 5, 6 9, 12 13, 15
A0 X 11, 13 10, 11 8, 9 28, 32.2 11, 13 10, 12 5, 6 9, 12 13, 15
B X 10, 12 8, 11 10, 13 29.2, 33.2 11, 12 8, 12 7, 9 8, 11 16, 18
B0 X 10, 12 8, 11 10, 13 29.2, 33.2 11, 12 8, 12 7, 9 8, 11 16, 18
C X 10, 11 9, 11 8, 10 29, 33.2 11, 12 10, 11 6, 9 8, 11 14, 15
C0 X 10, 12 9, 11 8, 10 29, 33.2 11, 12 10, 11 6, 9 8, 11 14, 15
D X 11, 12 9, 13 9, 10 29 14, 16 9, 12 6, 10 8, 12 16
D0 X 11, 13 9, 13 9, 10 29 14, 16 9, 12 6, 10 8, 12 16
E X 12 11, 12 9, 13 31.2, 32.2 10, 12 10, 11 6, 8 8, 10 18
E0 X 12 11, 12 9, 13 31.2, 32.2 10, 12 10, 11 6, 8 8, 10 18
F X 11, 12 8, 13 10, 11 29, 30 11 9, 11 7, 9 8, 10 18
F0 X 11, 12 8, 13 10, 11 29, 30 11 9, 11 7, 9 8, 10 18
G X 11, 12 12 11 29, 30 11 9 6, 9 8, 12 15, 18
G0 X 11, 12 12 11 29, 30 11 9 6, 9 8, 12 15, 18
H X, Y 10, 12 12 12, 13 29, 30 10, 12 10 7 7, 8 16, 18
H0 X, Y 10, 12 12 12, 13 29, 30 10, 12 10 7 7, 8 16, 18
I X 10, 14 12 9, 11 27, 28 11, 12 8, 9 9 11 15, 17
I0 X 10, 14 12 9, 11 27, 28 11, 12 8, 9 9 11 15, 17
J X, Y 10 12, 13 8, 14 32.2 9, 12 10, 12 9, 9.3 11 15
J0 X, Y 10 12, 13 8, 14 32.2 9, 12 10, 12 9, 9.3 11 15
Four cell lines were compared with the original tissue (A and A0, B and B0, C and C0, D and D0), 3 cell lines were compared with
frozen blood from the original donor (E and E0, F and F0, G and G0), and 3 cell lines were compared with FTA punch (H and H0, I and
I0, J and J0)
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Multiplex PCR methods through the distinct steps of
cell line generation process. When we used 5 STRs
and 10 STRs loci detection for checking cell lines
authentication comparing to tissue and blood samples
from the corresponding donors, good results were
obtained of sensitivity and reliability. However reli-
able results were obtained for FTA punches tested
with the 10 STRs Multiplex PCR method but not with
the 5 STRs Multiplex PCR method. We hypothesize
that it can be due to low DNA concentration in FTA
punches, being probably the 10 STRs Multiplex PCR
method more robust, sensitive and reliable for this
kind of samples because of less DNA quantity
required for STRs detection. Although technique
complexity is higher, the fingerprint using 10 STRs
loci provides an exact, sensitive, precise and objective
result through capillary electrophoresis in an analyzer
(Table 3), which allows comparing DNA fingerprints
across several experimental runs and sharing between
laboratories and public online databases (Romano
et al. 2009). On the contrary, the 5 STRs PCR method
requires training of technician for low resolution
agarose gel interpretation and the obtained results will
always be subjective. The main disadvantage of 10
STRs Multiplex PCR method versus 5 STRs loci
detection method is the higher costs per assay
(Table 3) but Multiplex 10 STRs loci detection
method has been recognized and approved by Amer-
ican National Standards Institute (ANSI) and Amer-
ican Type Culture Collection (ATCC).
Currently, prestigious scientific journals require
evidence of cell lines authentication and absence of
cross-contamination before data publication using
immortalized cell lines (Lichter et al. 2010) as well
as evidence of absence of contamination by my-
coplasma (Hancocks 2013). However, examples such
as the misidentified NCI/ADR-RES cell lines have
been revealed, which were used for publishing around
300 papers (Liscovitch and Ravid 2007), or clinical
trials and patents described using misidentified cell
Table 2 Features For conventional and real-time PCR mycoplasma detection methods
PCR LookOut Mycoplasma pcr detection
kit (Sigma-Aldrich) ? Agilent Bionalizer
PCR LookOut Mycoplasma qPCR
detection kit (Sigma-Aldrich)
Valid results obtained 100% 100%
Sensitivity 4–40 genome copies per assay 4–40 genome copies per assay
Number of species 19 66
Manipulation High Low
Result Qualitative Quantitative
Interpretation complexity Medium Easy. Numeric result (Ct value)
Cost/assay 23.73 € 19.37 €
Summary of special features for conventional PCR LookOut Mycoplasma PCR detection kit (Sigma Aldrich) and Agilent Bionalizer
visualization, compared with real-time LookOut Mycoplasma qPCR detection kit (Sigma Aldrich)
Table 3 Advantages And disadvantages for both STRS analysis methods
5 STRs detection method 10 STRs detection method
(Geneprint 10 System, Promega)
Discrimination between individual samples Yes Yes
STRs analysed 5 10
Methodology PCR ? Agarose electrophoresis PCR ? Capilar electrophoresis
Tecnich complexity Medium High
Interpretation Sometimes a bit subjective,
depending user expertise
Objective (high sensitivity and
resolution)
Cost/assay 13.07 € 47.97 €




lines (Boonstra et al. 2010). By other hand, some top
peer-reviewed journals present publications having
some of the most contaminated series of cells with
mycoplasma (Olarerin-George and Hogenesch 2015).
In conclusion, mycoplasma detection and authen-
tication by validated methods of newly established or
received cell lines prior to entering cell line collections
is an essential issue. Literature and cell bank websites
revision to find information about previous cross-
contamination, and periodically testing of cell lines
before cryopreservation and when thawed from liquid
nitrogen is considered a good cell culture practice
(Freshney 2010). In case of biobanks, cell lines’
checking is mandatory to provide a high-quality
bioresource for research. Biobanks have to implement
a consistent system for guaranteeing the authentica-
tion and to avoid the spreading of misidentified cells
lines as well as the absence of mycoplasma in the
supplied cell lines. This is the reason because highly
recommended methods have been routinely intro-
duced in the SSPA’s biobank for mycoplasma con-
tamination and cell line authentication testing.
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